Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

NCT06712628

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Gemeinschaftspraxis Innere Medizin/Rheumatologie /ID# 278584 Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Rheumapraxis Heidelberg /ID# 276475 Heidelberg, Baden-Wurttemberg, Germany
  • Rheumapraxis Ulm Dr. med. Nadia Rinaldi /ID# 276293 Ulm, Baden-Wurttemberg, Germany
  • Dr. Med. Thomas Marycz /ID# 274646 Amberg, Bavaria, Germany
View all 72 locations
View Trial Details
Recruiting

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

NCT06943469

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • AZ Sint-Jan Brugge-Oostende AV - Campus Sint-Jan Bruges, Belgium
  • Universitair Ziekenhuis Brussel - Kinderziekenhuis Brussels, Belgium
  • Clinique Ste Elisabeth Namur, Belgium
  • CHU Amiens Picardie Amiens, France
View all 25 locations
View Trial Details
Recruiting

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

NCT07201129

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Dolphin Medical Research Doral, Florida, United States
  • Alloy Clinical Research LLC Kissimmee, Florida, United States
  • SouthCoast Research Center Miami, Florida, United States
  • Allied Biomedical Research Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Recruiting

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

NCT06830720

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Novartis Investigative Site Wiener Neustadt, Lower Austria, Austria
  • Novartis Investigative Site Innsbruck, Tyrol, Austria
  • Novartis Investigative Site Linz, Upper Austria, Austria
  • Novartis Investigative Site Graz, Austria
View all 287 locations
View Trial Details

Related conditions